Skip to main content
. 2021 Jan 20;16(1):e0245752. doi: 10.1371/journal.pone.0245752

Table 3. First documented supraventricular tachycardia in isolated pre-capillary pulmonary hypertension.

Clinical classification of PH Total n = 641 Group 1 PH Group 3 PH Group 4 PH Group 5 PH P value
PAH Idiopathic/heritable n = 220 PAH associated with CTD n = 62 PAH associated with CHD n = 52 Lung disease/hypoxia n = 140 CTEPH No PEA n = 130 Unclear/Multifactorial n = 37
No of patients with SVT 162 (25%) 54 (25%) 18 (29%) 18 (35%) 23 (16%) 39 (30%) 10 (27%) 0.01
Typical AFL 28 (4.4%) 12 (5.5%) 2 (3.2%) 3 (5.8%) 1 (0.7%) 8 (6.2%) 2 (5.4%) NS
AF total 110 (17%) 34 (16%) 16 (26%) 9 (17%) 20 (14%) 25 (19%) 6 (16%) 0.01
AF paroxysmal 49 (7.6%) 9 (4.0%) 10 (16%) 4 (7.7%) 11 (7.8%) 13 (10%) 2 (5.4%) NS
AF persistent 23 (3.6%) 9 (4.0%) 2 (3.2%) 2 (3.8%) 1 (0.7%) 6 (4.6%) 3 (8.1%) NS
AF permanent 38 (5.9%) 16 (7.3%) 4 (6.4%) 3 (5.8%) 8 (5.7%) 6 (4.6%) 1 (2.7%) NS
AVNRT 4 (0.6%) 1 (0.5%) 0 1 (1.9%) 0 1 (0.8%) 1 (2.7%) NS
AVRT 0 0 0 0 0 0 0 -
Focal AT 1 (0.2%) 0 0 1 (1.9%) 0 0 0 -
Other AT 19 (3.0%) 7 (3.2%) 0 4 (7.7%) 2 (1.4%) 5 (3.8%) 1 (2.7%) NS
Proportion of patients with SVT onset prior to diagnosis of PH 51 (8.0%) 13 (5.9%) 8 (13%) 5 (9.6%) 7 (5%) 14 (11%) 4 (11%) NS
-at diagnosis of SVT and PH 49 (7.6%) 14 (6.4%) 6 (9.7%) 6 (12%) 6 (4.3%) 14 (11%) 3 (8.1%) NS
- after diagnosis of PH 62 (9.7%) 27 (12%) 4 (6.5%) 7 (13%) 10 (7.1%) 11 (8.5%) 3 (8.1%) NS

Values are expressed as n (%). P-value shows differences among major classes. NS–non-significant. PH–pulmonary hypertension; PAH–pulmonary arterial hypertension; CTD–connective tissue disease; CHD–congenital heart disease; CTEPH–chronic thrombembolic pulmonary hypertension; AFL–atrial flutter; AF–atrial fibrillation; AVNRT–atrio-ventricular nodal reentry tachycardia; AVRT–atrio-ventricular reentry tachycardia; AT–atrial tachycardia.